DACLIZUMAB - INJECTION
Common Brand Name(s): Zenapax
Phonetic Pronunciation: (dack-LIZ-you-mab)
Information last revised October 2010
Daclizumab is used to prevent rejection of a kidney transplant. It works by weakening your body's defense system (immune system) to help your body accept the new kidney as if it were your own. This medication is a monoclonal antibody and belongs to a class of drugs known as immunosuppressants. It is used in combination with other immunosuppressant drugs (e.g., cyclosporine, corticosteroids such as prednisone).
This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
The information contained in the First DataBank databases is intended to supplement the knowledge of physicians, pharmacists, and other healthcare professionals regarding drug therapy problems and patient counselling information. This information is advisory only and is not intended to replace sound clinical judgment in the delivery of healthcare services. First DataBank disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, and suitability of this information for any purpose.
Copyright 2010 First DataBank, Inc.